Trademarkia Logo

Canada

C$
Trademark Search in Canada
STRESSGEN BIOTECHNOLOGIES & BUBBLE & DESIGN

View On IC.GC.CA

STRESSGEN BIOTECHNOLOGIES & BUBBLE & DESIGN
REGISTERED

on 7 Dec 2007

Last Applicant/ Owned by

ENZO LIFE SCIENCES INC. (A NEW YORK CORPORATION)

81 Executive Blvd, Suite 3Farmingdale, NY 11735

US

Serial Number

1097717 filed on 27th Mar 2001

Registration Number

TMA702556 registered on 7th Dec 2007

Registration expiry Date

7th Dec 2032

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

STRESSGEN BIOTECHNOLOGIES & BUBBLE & DESIGN

Trademark usage description

reagent products, namely, proteins, antibodies, peptides and immunotherapeutics for academic, government, scientific and medical research; pharmaceut Read More

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

1 . 15 . 21

Bubbles, frothy masses -- Note: Including speech bubbles.Bulles, masses mousseuses -- Note: Y compris les bulles de bandes dessinées.

1 . 15 . 15

DropsGouttes

24 . 17 . 5

Mathematical signsSignes mathématiques

24 . 17 . 8

Symbol of infinitySigne de l'infini

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [001]
Reagent products, namely, proteins, antibodies, peptides and immunotherapeutics for academic, government, scientific and medical research;

Classification kind code

11

Class [005]
Pharmaceutical preparations for the treatment of human papillomavirus (HPV) types and HPV-related diseases, precancers and cancers, namely recurrent respiratory papillomatosis, genital warts, anal dysplasia, cervical dysplasia, anal cancers, head cancers, neck cancers, and cervical cancers, as well as for the treatment of diseases caused by hepatitis B, hepatitis C and herpes simplex viruses

Classification kind code

11

Mark Details

Serial Number

1097717

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 3rd Sept 2003		Advertised
Submitted for opposition 26
on 28th Jul 2003		Approved
Submitted for opposition 15
on 24th Feb 2003		Correspondence Created
Submitted for opposition 20
on 21st Aug 2002		Examiner's First Report
Submitted for opposition 22
on 30th Jul 2002		Search Recorded
Submitted for opposition 67
on 9th Jul 2001		Agent Name Changed
Submitted for opposition 68
on 9th Jul 2001		Rep for Service Name Changed
Submitted for opposition 31
on 18th Apr 2001		Formalized
Submitted for opposition 1
on 3rd Apr 2001		Created
Submitted for opposition 30
on 27th Mar 2001		Filed